Showing 321-330 of 1039 results for "".
A Multidisciplinary Toolbox for Atopic Dermatitis Treatments
https://practicaldermatology.com/topics/atopic-dermatitis/a-multidisciplinary-toolbox-for-atopic-dermatitis-treatments/23445/What to Look for in an Investment Advisor
https://practicaldermatology.com/topics/practice-management/what-to-look-for-in-an-investment-advisor/21018/Avoid choosing the wrong firm.Characterizing “Obese Skin”: Aesthetic Considerations Following GLP-1-Induced Rapid Weight Loss
https://practicaldermatology.com/topics/cosmetic/characterizing-obese-skin/24565/Characterizing “Obese Skin”: Aesthetic Considerations Following GLP-1-Induced Rapid Weight LossHPV and Genital Warts
https://practicaldermatology.com/topics/general-topics/hpv-and-genital-warts/20756/Combating the most common STD with vaccines and promising new treatments.The Biggest Developments in Dermatology: Drs. Tsao and Friedlander Provide Updates at Maui Derm
https://practicaldermatology.com/issues/january-february-2025/the-biggest-developments-in-dermatology-drs-tsao-and-friedlander-provide-updates-at-maui-derm/32937/The development of new therapeutics for dermatologic conditions in recent years has been so prolific that Hensin Tsao, MD, PhD, adopted a “Maui Journal of Medicine” theme for his conference-opening presentation at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.Letter to the Editor
https://practicaldermatology.com/columns/letter-to-the-editor/letter-to-the-editor-2/23905/A Definitive Guide to Recognizing and Treating “Maskne”
https://practicaldermatology.com/columns/clinical-focus-1/a-definitive-guide-to-recognizing-and-treating-maskne/23520/Practical Dermatology® magazine’s resident acne columnist offers step-by-step guidance.Advanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-management-solutions-for-high-grade-cutaneous-toxicities-to-cancer-therapy/57176/The emergence of immune checkpoint inhibitors (ICIs) has fundamentally altered the prognosis for patients with advanced skin malignancies, yet the high incidence of cutaneous immune-related adverse events (irAEs) remains a significant barrier to treatment continuity. Here, we review the clinical manClinical Updates on Psoriasis Management
https://practicaldermatology.com/topics/psoriasis/clinical-updates-on-psoriasis-management/21496/Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).